SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck is trending as investors focus on the potential for strategic acquisitions to bolster its oncology pipeline ahead of key patent expirations. Community sentiment is heavily centered on rumors of a bidding war for various biotech targets as the pharma giant seeks to secure the next generation of cancer treatments.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending as investors digest a recent $200 million equity offering while anticipating the upcoming IZAR-1 Phase 3 trial results for its psoriatic arthritis asset. The community is actively debating the company's valuation and the potential for a near-term buyout by major pharmaceutical players following its established best-in-class performance in hidradenitis suppurativa.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is facing intense volatility and a significant price correction following the discovery of a critical vulnerability in its Orchard pool that could have potentially enabled unauthorized token creation. While the team has released a patch, the community remains divided and deeply concerned over the inability to definitively audit the supply to confirm if any tokens were minted while the flaw was active.

Mastercard, Inc. is a technology company, which engages in the provision of payment solutions for the development and implementation of credit, debit, prepaid, commercial, and payment programs through its brands including Mastercard, Maestro, and Cirrus. It also offers cyber and intelligence solutions. The company was founded in November 1966 and is headquartered in Purchase, NY.

Mastercard Incorporated - Ordinary Shares - Class A

Mastercard Inc

Mastercard is drawing investor attention as it navigates regulatory uncertainty regarding potential credit card interest rate caps while simultaneously expanding its footprint in blockchain and stablecoin infrastructure through strategic acquisitions. Despite these policy headwinds, the community remains focused on the firm's core fundamental strength as a digital payment backbone with durable margins and robust transaction volume growth.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ai is trending as investors weigh potential institutional accumulation against ongoing concerns over revenue growth and persistent short interest. While recent CEO leadership changes and institutional stake increases have sparked debate, the community remains divided over whether the company can successfully pivot to agentic AI and secure the large-scale government contracts needed to drive a turnaround.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson is currently garnering attention as investors rotate into defensive, high-quality healthcare names amid broader market volatility. The community remains focused on the company's strong dividend track record, recent positive clinical trial updates for its oncology pipeline, and active discussions surrounding potential M&A activity within the pharmaceutical sector.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML remains a central focus as the semiconductor industry grapples with supply chain bottlenecks and rising capex from major manufacturers, reinforcing its status as a critical lithography monopoly. Community sentiment is currently driven by a mix of long-term conviction in the AI infrastructure buildout and short-term volatility following analyst target upgrades and debates over the adoption curve of its next-generation lithography equipment.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is facing intense selling pressure and negative sentiment, with many community members expressing deep frustration over its disconnect from broader market trends and the departure of key institutional support. While some investors view current price levels as a potential accumulation opportunity for a long-term turnaround, many are actively debating whether the project's real-world utility can overcome persistent volatility and lack of bullish momentum.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco Systems is surging following an impressive earnings report that signaled a major AI infrastructure pivot, fueled by record hyperscaler orders and a boosted outlook. The community is actively debating the stock's transition from a legacy networking player to a key AI infrastructure beneficiary, with many investors comparing its current trajectory to past dot-com era cycles.

Lighter is a decentralized trading platform built for unmatched security and scale. It’s the first exchange to offer verifiable order matching and liquidations while delivering best-in-class performance on par with traditional exchanges.

lighter

Lighter (LIT) is seeing increased attention driven by its strategic integration with Robinhood Chain and a significant token burn that reduced the circulating supply. Community members are actively debating the potential of this decentralized perpetuals exchange, with many focusing on its performance relative to competitors and the bullish outlook surrounding its revenue-sharing model.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

John B. Sanfilippo & Son to Present and Host 1x1 Investor Meetings at the 16th Annual East Coast IDEAS Investor Conference on June 10th & 11th in New York, NY

John B. Sanfilippo & Son (NASDAQ: JBSS) today announced management will present at the East Coast IDEAS Investor Conference on Thursday June 11, 2026 at The Westin Times Square in New York, NY. The Companys presentation is scheduled to begin at 9:55am ET and will hold investor meetings throughout...

John B. Sanfilippo & Son, Inc. Voluntarily Recalls Snack Mix Products Due to Possible Health Risk

As a follow up to the voluntary recall of dry milk powder by California Dairies, Inc. due to the potential presence of Salmonella, John B. Sanfilippo & Son, Inc. (Nasdaq: JBSS) (the Company) announced today that it is voluntarily recalling certain snack mix items listed below that were flavored...

Wall Street Zen Downgrades John B. Sanfilippo & Son (NASDAQ:JBSS) to Buy

Wall Street Zen cut John B. Sanfilippo & Son from a "strong-buy" rating to a "buy" rating in a research note on Saturday...

John B. Sanfilippo & Son Q3 Earnings Call Highlights

John B. Sanfilippo & Son (NASDAQ:JBSS) reported fiscal third-quarter 2026 results highlighted by record net sales growth driven primarily by higher pricing, while profitability declined year over...

Sanfilippo & Son (JBSS) Q3 Earnings and Revenues Surpass Estimates

John B. Sanfilippo (JBSS) delivered earnings and revenue surprises of +23.70% and +8.03%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

John B. Sanfilippo & Son (NASDAQ:JBSS) Releases Earnings Results, Beats Estimates By $0.27 EPS

John B. Sanfilippo & Son (NASDAQ:JBSS - Get Free Report) announced its earnings results on Wednesday. The company reported $1.43 EPS for the quarter, beating analysts' consensus estimates of $1.16 by...

John B. Sanfilippo & Son, Inc. Reports Fiscal 2026 Third Quarter Results

John B. Sanfilippo & Son, Inc. (NASDAQ: JBSS) (the Company) today announced financial results for its fiscal 2026 third quarter ended March 26, 2026. Third Quarter Summary Net sales increased $20.9...

John B. Sanfilippo & Son (JBSS) Projected to Post Quarterly Earnings on Wednesday

John B. Sanfilippo & Son (NASDAQ:JBSS) will be releasing its Q3 2026 earnings after the market closes on Wednesday, April 29. (View Earnings Report at...

Lamb Weston (LW) Q3 Earnings and Revenues Top Estimates

Lamb Weston (LW) delivered earnings and revenue surprises of +18.42% and +5.40%, respectively, for the quarter ended February 2026. Do the numbers hold clues to what lies ahead for the stock?

John B. Sanfilippo & Son, Inc. Declares $1.50 Per Share Special Dividend

John B. Sanfilippo & Son, Inc. (NASDAQ: JBSS) (the Company) today announced that its Board of Directors (the Board) declared a special cash dividend (the Special Dividend) of $1.50 per share on all...

John B. Sanfilippo & Son, Inc. engages in the processing and distribution of nuts and nut-related products. It offers peanuts, pecans, cashews, walnuts, almonds, and other nuts under the brands of Fisher, Orchard Valley Harvest, Squirrel Brand, and Southern Style Nuts. The company was founded by Gaspare Sanfilippo and John B. Sanfilippo in 1922 and is headquartered in Elgin, IL.

Sanfilippo (John B.) & Son, Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$87.17
Prev Close	$86.56
Open	$86.61
Dividend Yield	1.35%
50-Day Moving Average	$79.48
Beta	0.21
Avg. Volume	141,149.56
PE Ratio	15.28

52-Week High	$92.08
52-Week Low	$57.19
Market Capitalization	$1.02B
EPS (Annual)	$5.03
Price to Book	2.63
Revenue Per Employee	$582,761.05

Feed

News

Sentiment

Earnings

Fundamentals

Info

JBSSSanfilippo (John B.) & Son, Inc

Latest JBSS News